← Back to Analyst Consensus 
SBFM Buy
Sunshine Biopharma Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2025 | Aegis Capital | reiterate | Buy → Buy | $7 | — |
| Dec 5, 2024 | Aegis Capital | reiterate | Buy → Buy | $15 | — |
| Aug 7, 2023 | Aegis Capital | initiate | — → Buy | $2.6 | — |
Price Target Trend
Apr 14, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days